ProQR Therapeutics N.V. Stock
Price
Target price
€1.51
€1.51
0.600%
0.009
0.600%
€7.56
03.06.25 / Stuttgart Stock Exchange
WKN: A12B97 / Symbol: PRQR / Name: ProQR / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
ProQR Therapeutics N.V. Stock
The ProQR Therapeutics N.V. stock is trending slightly upwards today, with an increase of €0.009 (0.600%) compared to yesterday's price.
With 10 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 1.51 € the target price of 7 € shows a potential of 363.27% for ProQR Therapeutics N.V. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the ProQR Therapeutics N.V. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Company culture" there were negative voices in the community.
Pros and Cons of ProQR Therapeutics N.V. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ProQR Therapeutics N.V. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | 0.600% | 3.159% | 1.831% | -12.471% | -41.873% | 113.656% | -68.312% |
| Pharming Group | 1.540% | 8.616% | 31.230% | 27.843% | 12.554% | 37.748% | -20.000% |
| Ardelyx Inc. | 1.160% | -1.371% | -5.399% | -45.672% | -30.473% | 451.614% | -47.298% |
| Krystal Biotech | -0.950% | 2.627% | -21.519% | -23.498% | -24.277% | 125.980% | - |
Comments
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $9.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $5.00 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat